Cargando…
Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9
Site-specific modification of antibodies has become a critical aspect in the development of next-generation immunoconjugates meeting criteria of clinically acceptable homogeneity, reproducibility, efficacy, ease of manufacturability, and cost-effectiveness. Using CRISPR/Cas9 genomic editing, we deve...
Autores principales: | Khoshnejad, Makan, Brenner, Jacob S., Motley, William, Parhiz, Hamideh, Greineder, Colin F., Villa, Carlos H., Marcos-Contreras, Oscar A., Tsourkas, Andrew, Muzykantov, Vladimir R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789018/ https://www.ncbi.nlm.nih.gov/pubmed/29379029 http://dx.doi.org/10.1038/s41598-018-19784-2 |
Ejemplares similares
-
The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series)
por: Brenner, Jacob S., et al.
Publicado: (2017) -
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
por: Brenner, Jacob S., et al.
Publicado: (2018) -
Covalent Modification of Bacteriophage T4 DNA Inhibits CRISPR-Cas9
por: Bryson, Alexandra L., et al.
Publicado: (2015) -
Collaborative Enhancement of Antibody Binding to Distinct PECAM-1 Epitopes Modulates Endothelial Targeting
por: Chacko, Ann-Marie, et al.
Publicado: (2012) -
Targeting to Endothelial Cells Augments the Protective
Effect of Novel Dual Bioactive Antioxidant/Anti-Inflammatory Nanoparticles
por: Howard, Melissa D., et al.
Publicado: (2014)